Wei Li
8 Papers
29 Citations
Wei Li is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Targeted metabolomics for serum amino acids and acylcarnitines in patients with lung cancer.
TL;DR: The PLS-DA model using the six metabolites (glycine, valine, methionine, citrulline, arginine and C16-carnitine) had a strong ability to identify lung cancer.
Simultaneous determination of thirteen kinds of amino acid and eight kinds of acylcarnitine in human serum by LC–MS/MS and its application to measure the serum concentration of lung cancer patients
Junjun Ni,Li Xu,Wei Li,Lijun Wu +3 more
TL;DR: A novel, sensitive and specific liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to simultaneously determine 13 amino acids and 8 acylcarnitines in lung cancer patients in serum showed that the serum concentration of Lung cancer patients were significant from those of healthy controls.
29
Association of KMT2C/D loss‐of‐function variants with response to immune checkpoint blockades in colorectal cancer
Ruiqi Liu,Y. Niu,Chao Liu,Xin Zhang,Jinku Zhang,Min Shi,Wenbo Zou,Binbin Gu,Honglin Zhu,Danhua Wang,Hongling Yuan,Wei Li,Dandan Zhao,Qiaosong Zheng,Rong Li,Weiping Chen,Tonghui Ma,Yanqiao Zhang +17 more
TL;DR: Wang et al. as mentioned in this paper investigated the associations of KMT2C/D loss-of-function (LOF) variants with tumor mutation burden (TMB), MSI•H, PD•L1 expression, and clinical response to ICIs.
17
Molecular characterization of genomic breakpoints of ALK rearrangements in non‐small cell lung cancer
Zizong Wang,Yushuai Han,H. Tao,Mengxiang Xu,Zhengchuang Liu,Jia-yao Zhu,Wei Li,Jie Ma,Zhifang Liu,Weiran Wang,Tonghui Ma +10 more
TL;DR: In this article , a total of 783 ALK rearrangement-positive non-small cell lung cancer cases were identified by DNA-based next-generation sequencing (NGS), including 731 patients with EML4−ALK and 52 patients with other rearrangements.
5
Profiling of gene fusion involving targetable genes in Chinese gastric cancer
Zhenhao Liu,Bo Zhu,Min Shi,Yurong Qu,Hong-ling Yuan,Jie Ma,Wei Li,Dan-Dan Zhao,Zhengchuang Liu,Baoxun Wang,Chun Yang Wang,Hou-Quan Tao,Tonghui Ma +12 more
TL;DR: Gene fusion detection may provide a potential treatment strategy for patients with GC with disease progression following standard therapy and there were no significant differences between fusion-positive and fusion-negative patients in age, sex, MSI status, and TMB.
3